Work

Re: Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients with Renal Cell Carcinoma

Year: 2012

Type: letter

Source: The Journal of Urology

DOI: 10.1016/j.juro.2012.08.170

Author: Samir S. Taneja

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2114458529

Cites:

Cited by: 10

Related to: 10